Copeland Capital Management, LLC Eli Lilly & CO Transaction History

Copeland Capital Management, LLC

  • $5.61 Billion
  • Q3 2024

A detailed history of Copeland Capital Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Copeland Capital Management, LLC holds 25,369 shares of LLY stock, worth $20.2 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares
25,369
Previous 26,363 3.77%
Holding current value
$20.2 Million
Previous $23.9 Million 5.84%
% of portfolio
0.4%
Previous 0.46%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024
SELL
$772.14 - $960.02 $767,507 - $954,259
-994 Reduced 3.77%
25,369 $22.5 Million
Q2 2024

Jul 26, 2024
BUY
$724.87 - $909.04 $642,234 - $805,409
886 Added 3.48%
26,363 $23.9 Million
Q1 2024

Apr 19, 2024
BUY
$592.2 - $792.28 $1.13 Million - $1.51 Million
1,900 Added 8.06%
25,477 $19.8 Million
Q4 2023

Jan 19, 2024
BUY
$525.19 - $619.13 $4.89 Million - $5.77 Million
9,318 Added 65.35%
23,577 $13.7 Million
Q3 2023

Oct 23, 2023
SELL
$434.7 - $599.3 $147,798 - $203,761
-340 Reduced 2.33%
14,259 $7.66 Million
Q2 2023

Jul 14, 2023
BUY
$350.74 - $468.98 $4.64 Million - $6.2 Million
13,217 Added 956.37%
14,599 $6.85 Million
Q1 2020

Jan 18, 2022
BUY
$119.05 - $147.35 $164,527 - $203,637
1,382 New
1,382 $192,000
Q1 2020

Apr 29, 2020
SELL
$119.05 - $147.35 $164,527 - $203,637
-1,382 Closed
0 $0
Q4 2019

Jan 18, 2022
BUY
$106.92 - $132.43 $147,763 - $183,018
1,382 New
1,382 $182,000
Q4 2019

Feb 03, 2020
SELL
$106.92 - $132.43 $147,763 - $183,018
-1,382 Closed
0 $0
Q3 2019

Jan 18, 2022
BUY
$106.79 - $116.16 $147,583 - $160,533
1,382 New
1,382 $155,000
Q3 2019

Nov 06, 2019
SELL
$106.79 - $116.16 $147,583 - $160,533
-1,382 Closed
0 $0
Q2 2019

Jan 18, 2022
BUY
$110.79 - $129.32 $153,111 - $178,720
1,382 New
1,382 $153,000
Q2 2019

Jul 19, 2019
SELL
$110.79 - $129.32 $153,111 - $178,720
-1,382 Closed
0 $0
Q1 2019

Jan 18, 2022
BUY
$111.31 - $131.02 $153,830 - $181,069
1,382 New
1,382 $179,000
Q1 2019

Apr 24, 2019
SELL
$111.31 - $131.02 $178,096 - $209,632
-1,600 Closed
0 $0
Q4 2018

Jan 18, 2022
BUY
$105.9 - $118.64 $169,440 - $189,824
1,600 New
1,600 $185,000

Others Institutions Holding LLY

# of Institutions
4,011
Shares Held
751M
Call Options Held
8.27M
Put Options Held
10.5M
View Full List

About ELI LILLY & Co

LLY Quotes by TradingView
  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Copeland Capital Management, LLC Portfolio

Follow Copeland Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Copeland Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Copeland Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email